肝移植术中凝血因子监测及出凝血药物的应用
被引量:2
摘要
随着临床外科学、麻醉学及输血学等学科的发展,肝移植的成功率有很大提高,病人术后生存时间明显延长。国外文献报道1年存活率为80%~90%,最长生存时间超过26年。由于接受肝脏移植的多为终末期肝病病人,围手术期的出血是临床上面临的棘手问题。因此,充分的准备及术中、术后完善的止凝血实验室监测,及时、合理地使用血液及其制品治疗,是手术成功的关键。
出处
《中华肝胆外科杂志》
CAS
CSCD
2006年第2期122-124,共3页
Chinese Journal of Hepatobiliary Surgery
参考文献8
-
1Hendriks HGD,Meijer K,Dewolf ITM,et al.Detection of the influence of recombinant factor Ⅶ a on coagulation by thromboelastography in liver trans-plantation.Blood coagulation and fibrinolysis,2002,13:309-313.
-
2Porte RJ,Molenaar IQ,Begliomini B,et al.Aprotinin and transfusion requirements in orthotopic liver transplantation:a multicentre randomised double-blind study.EMSALT Study Group.Lancet,2000,355:1303-1309.
-
3Kalicicinnski A,Drewnisk T.Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor Ⅶ.Transplant Proc,1999,31:378.
-
4Bindi ML,Biancofiore GD,Consani G,et al.Blood coagulation monitoring during liver transplantation:sonoclot analysis and laboratory tests.Minerva Anestesiol,2001,7:359-369.
-
5Dupont J,Messiant F,Declerck N,et al.Liver transplantation without the use of fresh frozen plasma.Anesth Analg,1996,83:681-686.
-
6Molenaar IQ,Legnani C,Groenland TH,et al.Aprotinin in orthotopic liver transplantation:evidence for a prohemostatic,but not a prothrombotic,effect.Liver Transpl,2001,7:896-903.
-
7Marcel RJ,Stegall WC,Suit CT,et al.Continuous small-dose aprotinin controls fibrinolysis during orthotopic liver transplantation.Anesth Analg,1996,82:1122-1125.
-
8Frenette L,Cox J,Arnall M,et al.Effectiveness of conjugated estrogen in orthotopic liver transplantation.South Med J,1998,91:365-368.
同被引文献28
-
1Paolo Feltracco,Stefania Barbieri,Helmut Galligioni,Elisa Michieletto,Cristiana Carollo,Carlo Ori.Intensive care management of liver transplanted patients[J].World Journal of Hepatology,2011,3(3):61-71. 被引量:16
-
2李健.肝移植围手术期出血及其治疗[J].中华血液学杂志,2004,25(9):575-576. 被引量:5
-
3沈中阳.肝脏移植术后乙肝复发的综合防治[J].中国医学科学院学报,2005,27(4):431-434. 被引量:24
-
4王正昕,傅志仁,丁国善,郭闻渊,傅宏,倪之嘉,马钧,李先兴,施晓敏.肝移植术后预防乙型肝炎病毒再感染281例的分析[J].消化外科,2006,5(1):26-29. 被引量:6
-
5李健,魏宪义,傅志仁.拉米呋啶、乙肝免疫球蛋白防治肝移植术后HBV再感染的功效比较及临床应用进展[J].中华肝胆外科杂志,2007,13(8):568-570. 被引量:3
-
6Hendriks HGD, Meijer K, Dewolf ITM, et al . Detection the influence of recombinant factor VIIa on coagulation by thromboelastography in liver trans -plantation[ J]. Blood Coagulation and Fibrinolysis,2002,13 (4) :309-313.
-
7Martinowitz U, Holcomb JB, Pusateri AE, et al. Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries [ J ]. Trauma, 2001,50 (5) :721-729.
-
8Porte Pal, Molenaar IQ, Begliomini B, et al Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomised double-blind study [ S ]. EMSALT Study Group. Lancet,2000,15 ;355 (9212) :1303-1309.
-
9Kalicicinnski A, Drewnisk T . Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver trans - plantation by recombinant activated factor VII [ J ]. Transplant Proc, 1999,31:378.
-
10Bindi ML, Biancofiore GD, Consani G, et al. Blood coagulation monitoring during liver transplantation: Sonoclot analysis and laboratory tests[ J]. Minerva Anestesiol May,2001,67 (5) :359- 369.
引证文献2
-
1李健,庞跃林,蒋德席,王学锋.肝移植围手术期出血及其相关血液制品的临床应用[J].中国输血杂志,2008,21(5):403-406. 被引量:5
-
2莫小源,陶品月,秦科,卢舒雨,李涛,曾菲,梁奕,刘娟娟.成人肝移植病人围术期体温管理最佳证据总结[J].循证护理,2024,10(5):800-805.
二级引证文献5
-
1宋丽洁,姚桂玲,刘煜,赵怡雯,丁琪,崔娟红.亲体肝移植患者围手术期止血与凝血指标的变化[J].中国组织工程研究与临床康复,2010,14(31):5737-5740. 被引量:4
-
2蒋学兵,王洪波.临床输血与肝癌治疗研究进展[J].国际检验医学杂志,2011,32(9):977-979. 被引量:4
-
3蒋学兵,成海.肝移植围手术期输血研究进展[J].中国输血杂志,2011,24(7):627-630. 被引量:7
-
4刘志国,叶艳菲,冯艳青,王淑英.肝病患者血浆输注的现状[J].胃肠病学和肝病学杂志,2014,23(11):1252-1254. 被引量:7
-
5张浩,池萍,徐慧芳,张晶,林栋栋.肝移植患者围手术期血液制品的合理应用与规范化管理[J].临床药物治疗杂志,2020,18(1):17-20. 被引量:7
-
1李健.肝移植围手术期出血及其治疗[J].中华血液学杂志,2004,25(9):575-576. 被引量:5
-
2栗婷.低分子肝素治疗原发性肾病综合征临床观察[J].中国实用医药,2010,5(36):96-97.
-
3王学锋,王鸿利.肝移植术围手术期出血及其处理[J].外科理论与实践,2003,8(5):417-419.
-
4黄刚红.16例肝功能异常患者手术麻醉的探讨[J].中国卫生产业,2011,8(6):89-89.
-
5罗义麒,薛学义,林承杰,曹林升,林曦,缪思满,周辉良,郑清水.高龄患者肾移植的体会[J].福建医科大学学报,1997,31(1):70-72.
-
6曹娅丽,王世相.维持性血液透析患者乙型肝炎病毒感染研究现状[J].中国血液净化,2006,5(5):262-264. 被引量:7
-
7翁亚屏.预防和控制艾滋病刻不容缓[J].中华医学信息导报,1994,0(22):1-1+8.
-
8薛武军,陈勇,邢俊平,田普训.高危患者肾移植体会[J].中华泌尿外科杂志,1996,17(7):402-404. 被引量:3
-
9王晓箴,凌宝存.临床外科学21世纪发展趋势[J].临床军医杂志,2002,30(5):101-103. 被引量:2
-
10袁立新.滥用血液及其制品易感染丙型肝炎[J].中华医学信息导报,1994,9(8):10-10.